KPMG

GST rationalisation to reshape affordability and global competitiveness for Indian Pharma: KPMG

Read more

India’s life sciences sector: A vision for budget FY2025

Read more

Life sciences CEOs optimistic about company growth amid industry challenges

Read more

Pharma sector awaits Budget 2024 for innovation boost and regulatory reforms

Read more

Chinese threat looms large on Indian bulk drug industry

Read more